Skip to main content
. 2012 Oct 12;14(5):R216. doi: 10.1186/ar4055

Figure 2.

Figure 2

Comparisons of sclerostin serum levels in ankylosing spondylitis (AS) patients at baseline, 6 months and 12 months after anti-TNF therapy and in healthy controls.